Ignite Creation Date:
2025-12-25 @ 3:27 AM
Ignite Modification Date:
2026-01-09 @ 9:23 AM
Study NCT ID:
NCT03824405
Status:
COMPLETED
Last Update Posted:
2022-10-25
First Post:
2019-01-29
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of the Safety, Tolerability and Efficacy of BTX 1204 in Patients With Moderate Atopic Dermatitis
Sponsor:
Botanix Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-02-04
Start Date Type:
ACTUAL
Primary Completion Date:
2020-01-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-03-04
Completion Date Type:
ACTUAL
First Submit Date:
2019-01-29
First Submit QC Date:
None
Study First Post Date:
2019-01-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-08-31
Results First Submit QC Date:
None
Results First Post Date:
2022-09-27
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-09-30
Last Update Post Date:
2022-10-25
Last Update Post Date Type:
ACTUAL